Publication: Syntheses, Characterizations, and Hirshfeld Analysis of Ag(I) and Cu(II) Complexes: A Novel Potent Ag(I)-Based Oxadiazole Anticancer Agent
| dc.authorscopusid | 36522260500 | |
| dc.authorscopusid | 58157062300 | |
| dc.authorscopusid | 7003345213 | |
| dc.authorscopusid | 56107898800 | |
| dc.authorscopusid | 57193843134 | |
| dc.authorscopusid | 57201620841 | |
| dc.authorscopusid | 57201620841 | |
| dc.authorwosid | Soliman, Saied/I-7775-2013 | |
| dc.authorwosid | N, Dege/B-2545-2016 | |
| dc.authorwosid | Dege, Necmi/B-2545-2016 | |
| dc.authorwosid | Ayoup, Mohammed/Khe-0653-2024 | |
| dc.contributor.author | Ayoup, Mohammed Salah | |
| dc.contributor.author | ElShafey, Mariam M. | |
| dc.contributor.author | Abdel-Hamid, Hamida | |
| dc.contributor.author | Abu-Serie, Marwa M. | |
| dc.contributor.author | Teleb, Mohamed | |
| dc.contributor.author | Dege, Necmi | |
| dc.contributor.author | Soliman, Saied M. | |
| dc.contributor.authorID | Salah Ayoup, Mohammed/0000-0001-6715-5478 | |
| dc.contributor.authorID | N, Dege/0000-0003-0660-4721 | |
| dc.contributor.authorID | M El Shafey, Mariam/0000-0001-5474-4951 | |
| dc.date.accessioned | 2025-12-11T01:27:52Z | |
| dc.date.issued | 2023 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Ayoup, Mohammed Salah; ElShafey, Mariam M.; Abdel-Hamid, Hamida; Soliman, Saied M.] Alexandria Univ, Fac Sci, Dept Chem, Alexandria, Egypt; [Abu-Serie, Marwa M.] City Sci Res & Technol Applicat SRTA City, Genet Engn & Biotechnol Res Inst, Med Biotechnol Dept, Borg El Arab, Egypt; [Teleb, Mohamed] Alexandria Univ, Fac Pharm, Dept Pharmaceut Chem, Alexandria, Egypt; [Dege, Necmi] Ondokuz Mayis Univ, Fac Arts & Sci, Dept Phys, Samsun, Turkiye; [Ayoup, Mohammed Salah; Soliman, Saied M.] Alexandria Univ, Fac Sci, Dept Chem, POB 426, Alexandria 21321, Egypt | en_US |
| dc.description | Salah Ayoup, Mohammed/0000-0001-6715-5478; N, Dege/0000-0003-0660-4721; M El Shafey, Mariam/0000-0001-5474-4951 | en_US |
| dc.description.abstract | The Ag(I) and Cu(II) complexes of the ligand, 2,2 '-(1,2,4-oxadiazole-3,5-diyl) dianiline, (L; 4) were synthesized and characterized using different spectroscopic techniques. Their anticancer activities against three types of cancer cell lines were explored. The [AgL (NO3)](n) complex (5) has 1D polymeric structure whereas the [CuL (NO3)(2)] (6) and [CuLCl2] (7) are monomeric complexes. The Ag(I) in 5 is tetra-coordinated and has AgN2O2 coordination sphere where both L and NO3 over bar are bridging the Ag(I) sites along the polymer array. In 6 and 7, the coordination environments are CuN3O3 and CuN3Cl2, respectively. In both cases, the oxadiazole ligand is a tridentate chelate via two N-atoms from both amino groups and one N-atom from the oxadiazole moiety. Hirshfeld analysis revealed the importance of O horizontal ellipsis H (23.5%), H horizontal ellipsis H (24.8%), and C horizontal ellipsis C (6.6%) non-covalent interactions in the molecular packing of 5. In 6, the O horizontal ellipsis H (40.7%), N horizontal ellipsis H (4.9%), O horizontal ellipsis O (5.9%), N horizontal ellipsis O (3.2%), and C horizontal ellipsis N (2.2%) contacts are the most important. Regarding safety on normal human fibroblasts Wi-38, MTT assay for all metal complexes especially the Ag(I) complex 5 exhibited higher safety profiles than the free oxadiazole ligand as well as the standard chemotherapeutic drug 5-fluroruracil (5-FU). The cytotoxic activities of complexes 5-7 surpassed 5-FU against A549, Caco-2, and MDA-MB231 cell lines. 5 has the best anticancer activity (IC50 = 0.074, 0.085, and 0.533 mu M, respectively) and exhibiting pronounced selectivity index up to 44.3. Quantitative PCR analysis of BAX and BCL-2 revealed their apoptotic induction mechanism and showed that the metal complexes can repress the main oncogene BCL-2 and enhance the expression of proapoptotic gene BAX. Again, 5 is the most potent with 14.28 folds BCL-2 downregulation and 4.86 folds BAX upregulation. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.1002/aoc.7142 | |
| dc.identifier.issn | 0268-2605 | |
| dc.identifier.issn | 1099-0739 | |
| dc.identifier.issue | 8 | en_US |
| dc.identifier.scopus | 2-s2.0-85160026196 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1002/aoc.7142 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/43951 | |
| dc.identifier.volume | 37 | en_US |
| dc.identifier.wos | WOS:000994045400001 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.ispartof | Applied Organometallic Chemistry | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | 1 | en_US |
| dc.subject | 2 | en_US |
| dc.subject | 4-Oxadiazole | en_US |
| dc.subject | Anticancer | en_US |
| dc.subject | Bcl-2 | en_US |
| dc.subject | Coinage Metals (Ag(I) and Cu(II)) | en_US |
| dc.subject | Hirshfeld | en_US |
| dc.title | Syntheses, Characterizations, and Hirshfeld Analysis of Ag(I) and Cu(II) Complexes: A Novel Potent Ag(I)-Based Oxadiazole Anticancer Agent | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
